Uipath, INC Form 4 insider transactions
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $15.57 per share under a pre-arranged Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, reported the sale of 10,000 shares of Class A Common Stock for $15.68 per share under a pre-arranged 10b5-1 plan, with the transaction dated October 21, 2025.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 Class A Common Stock shares for approximately $15.71 each, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, sold 10,000 shares of Class A Common Stock for $15.65 each on October 20, 2025, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, sold 10,000 shares of Class A Common Stock for an average price of $15.7345 per share, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for $15.62 per share, executed under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines sold 122,734 shares of Class A Common Stock for approximately $2.1 million under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, sold 10,000 shares of Class A Common Stock on October 16, 2025, through a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's General Counsel and Chief Legal Officer, Brad Brubaker, sold 27,580 shares of Class A Common Stock for an average price of $16.6761 under a pre-arranged 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines sold 122,734 shares of Class A Common Stock for approximately $2.07 million under a pre-arranged Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, sold 20,000 shares of Class A Common Stock for approximately $332,152 through a pre-arranged 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath's COO & CFO, Ashim Gupta, exercised stock options and subsequently sold a significant number of Class A Common Stock shares under a pre-arranged Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold a total of 245,468 Class A Common Stock shares over two days in October 2025, pursuant to a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, reported a planned sale of 10,000 Class A Common Stock shares scheduled for October 13, 2025, under a Rule 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 122,734 shares of Class A Common Stock for approximately $2.25 million under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 122,734 shares of Class A Common Stock for an average price of $16.5743 per share, executed under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 122,734 shares of Class A Common Stock for approximately $1.83 million under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 122,733 shares of Class A Common Stock for approximately $1.84 million under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's GC & Chief Legal Officer, Brad Brubaker, sold 66,665 shares of Class A Common Stock for approximately $15.00 per share under a pre-arranged 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 122,733 shares of Class A Common Stock for approximately $1.75 million under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 122,733 shares of Class A Common Stock for an average price of $13.0057 per share under a pre-arranged 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 122,733 shares of Class A Common Stock for an average price of $12.8412 under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's COO & CFO, Ashim Gupta, had 71,009 shares withheld by the company to cover tax obligations related to the vesting of restricted stock units.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, disposed of 26,058 shares of Class A Common Stock to cover tax obligations related to RSU vesting.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 122,733 shares of Class A Common Stock for approximately $1.63 million through a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's General Counsel and Chief Legal Officer, Brad Brubaker, reported the sale of Class A Common Stock and shares withheld for tax obligations related to RSU vesting.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines reported a planned sale of 122,733 Class A Common Stock shares for September 30, 2025, under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 122,733 shares of Class A Common Stock for an average price of $12.3339 per share under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 122,733 shares of Class A Common Stock for approximately $1.48 million under a pre-arranged Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 122,733 shares of Class A Common Stock at an average price of $12.0167 under a pre-arranged 10b5-1 trading plan.